your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com
Uptodate Reference Title
Tirofiban reduces mortality in unstable angina
Tirofiban reduces mortality in unstable angina
The PRISM study randomly assigned 3232 patients with unstable angina to therapy with heparin or tirofiban. Tirofiban was associated with a significant reduction in 30-day mortality.
Data from The Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators. N Engl J Med 1998; 338:1498.
